Search research articles
Contact Us
Filters
Showing results (21-30 of 123) with videos related to
Page
of 13
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism
|
February 5, 2010
Rationale for treatment and therapeutic options in Cushing's disease
Paul M Stewart, Stephan Petersenn
Nature Reviews. Endocrinology
|
March 21, 2024
Reply to 'Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern'
Stephan Petersenn, Maria Fleseriu, Shlomo Melmed
Medizinische Klinik (Munich, Germany : 1983)
|
June 29, 2006
[Diagnosis and therapy of endocrine hypertension]
Nicole Unger, Stephan Petersenn, Klaus Mann
Nature Reviews. Endocrinology
|
January 22, 2024
Reply to 'The shift of therapeutic strategy for prolactinomas: surgery as the first-line option'
Stephan Petersenn, Maria Fleseriu, Shlomo Melmed
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 29, 2017
National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency
Stephan Petersenn, Jürgen Honegger, Marcus Quinkler
European Journal of Endocrinology
|
May 1, 2002
Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test
Stephan Petersenn, Roman Jung, Frank U Beil
European Journal of Endocrinology
|
October 28, 2008
Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test
Timo Deutschbein, Nicole Unger, Klaus Mann, et al.
MMW Fortschritte Der Medizin
|
April 7, 2010
[Arterial hypertension and subclinical Cushing's syndrome]
Martin Fassnacht, Felix Beuschlein, Marcus Quinkler, et al.
Nature Reviews. Endocrinology
|
June 17, 2024
Evidence for somatic mutation screening on aggressive prolactinomas
Marily Theodoropoulou, Stephan Petersenn, Philippe Chanson, et al.
Pituitary
|
December 28, 2019
Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study
Stephan Petersenn, Aude Houchard, Caroline Sert, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 123) with videos related to
Sort By:
Page
of 13
Best Practice & Research. Clinical Endocrinology & Metabolism
|
February 5, 2010
Rationale for treatment and therapeutic options in Cushing's disease
Paul M Stewart, Stephan Petersenn
Nature Reviews. Endocrinology
|
March 21, 2024
Reply to 'Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern'
Stephan Petersenn, Maria Fleseriu, Shlomo Melmed
Medizinische Klinik (Munich, Germany : 1983)
|
June 29, 2006
[Diagnosis and therapy of endocrine hypertension]
Nicole Unger, Stephan Petersenn, Klaus Mann
Nature Reviews. Endocrinology
|
January 22, 2024
Reply to 'The shift of therapeutic strategy for prolactinomas: surgery as the first-line option'
Stephan Petersenn, Maria Fleseriu, Shlomo Melmed
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 29, 2017
National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency
Stephan Petersenn, Jürgen Honegger, Marcus Quinkler
European Journal of Endocrinology
|
May 1, 2002
Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test
Stephan Petersenn, Roman Jung, Frank U Beil
European Journal of Endocrinology
|
October 28, 2008
Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test
Timo Deutschbein, Nicole Unger, Klaus Mann, et al.
MMW Fortschritte Der Medizin
|
April 7, 2010
[Arterial hypertension and subclinical Cushing's syndrome]
Martin Fassnacht, Felix Beuschlein, Marcus Quinkler, et al.
Nature Reviews. Endocrinology
|
June 17, 2024
Evidence for somatic mutation screening on aggressive prolactinomas
Marily Theodoropoulou, Stephan Petersenn, Philippe Chanson, et al.
Pituitary
|
December 28, 2019
Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study
Stephan Petersenn, Aude Houchard, Caroline Sert, et al.
Page
of 13